Stephanie J. Wang

发表

Therapeutically reprogrammed nutrient signalling enhances nanoparticulate albumin bound drug uptake and efficacy in KRAS-mutant cancer

Michelle A. Garlin, Miles A. Miller, D. Lauffenburger, 2021, Nature Nanotechnology.

Efficient blockade of locally reciprocated tumor-macrophage signaling using a TAM-avid nanotherapy

Miles A. Miller, D. Lauffenburger, R. Weissleder, 2020, Science Advances.

Reduced Proteolytic Shedding of Receptor Tyrosine Kinases Is a Post-Translational Mechanism of Kinase Inhibitor Resistance.

Hakho Lee, Ralph Weissleder, Douglas A Lauffenburger, 2016, Cancer discovery.

In vivo microscopy reveals macrophage polarization locally promotes coherent microtubule dynamics in migrating cancer cells

Miles A. Miller, D. Lauffenburger, R. Weissleder, 2020, Nature Communications.

Baseline tumor growth rate highlights the heterogeneity of well differentiated gastroenteropancreatic neuroendocrine tumors and predicts for increases in Ki67 index over time

E. Nakakura, S. Behr, T. Hope, 2023, Journal of neuroendocrinology.

Combined MEK and ERK inhibition overcomes therapy-mediated pathway reactivation in RAS mutant tumors

Lily Shao, Mark Merchant, Eva Lin, 2017, PloS one.

Correction: Combined MEK and ERK inhibition overcomes therapy-mediated pathway reactivation in RAS mutant tumors

M. Belvin, D. Kirouac, H. Koeppen, 2018, PloS one.

Pembrolizumab alone and pembrolizumab plus chemotherapy in previously treated, extrapulmonary poorly differentiated neuroendocrine carcinomas

N. Raj, P. Munster, L. Fong, 2023, British Journal of Cancer.

Reduced Proteolytic Shedding of Receptor Tyrosine Kinases Is a Post-Translational Mechanism of Kinase Inhibitor Resistance.

Miles A. Miller, Aaron S. Meyer, D. Lauffenburger, 2016, Cancer discovery.